These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
648 related items for PubMed ID: 17722021
21. Long-term outcome of transcatheter patent foramen ovale closure in patients with paradoxical embolism. Cifarelli A, Musto C, Parma A, Pandolfi C, Pucci E, Fiorilli R, De Felice F, Nazzaro MS, Violini R. Int J Cardiol; 2010 Jun 11; 141(3):304-10. PubMed ID: 19178959 [Abstract] [Full Text] [Related]
27. Outcomes after transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Harms V, Reisman M, Fuller CJ, Spencer MP, Olsen JV, Krabill KA, Gray WA, Jesurum JT. Am J Cardiol; 2007 May 01; 99(9):1312-5. PubMed ID: 17478164 [Abstract] [Full Text] [Related]
28. Spontaneous large right-to-left shunt and migraine headache with aura are risk factors for recurrent stroke in patients with a patent foramen ovale. Giardini A, Donti A, Formigari R, Salomone L, Palareti G, Guidetti D, Picchio FM. Int J Cardiol; 2007 Sep 03; 120(3):357-62. PubMed ID: 17166607 [Abstract] [Full Text] [Related]
29. Long-term efficacy of transcatheter patent foramen ovale closure on migraine headache with aura and recurrent stroke. Giardini A, Donti A, Formigari R, Salomone L, Palareti G, Guidetti D, Picchio FM. Catheter Cardiovasc Interv; 2006 Apr 03; 67(4):625-9. PubMed ID: 16548006 [Abstract] [Full Text] [Related]
30. Cardiac magnetic resonance imaging of atrial septal defect for transcatheter closure. Durongpisitkul K, Tang NL, Soongswang J, Laohaprasitiporn D, Nana A, Kangkagate C. J Med Assoc Thai; 2002 Aug 03; 85 Suppl 2():S658-66. PubMed ID: 12403244 [Abstract] [Full Text] [Related]
31. [Is transcatheter occlusion of a persistent foramen ovale a possibility for the avoidance of a paradoxical embolism?]. Berger F, Uhlemann F, Nürnberg JH, Haas NA, Lange PE. Dtsch Med Wochenschr; 1997 Nov 07; 122(45):1371-6. PubMed ID: 9410713 [Abstract] [Full Text] [Related]
34. Transcatheter patent foramen ovale closure is effective in reducing migraine independently from specific interatrial septum anatomy and closure devices design. Rigatelli G, Cardaioli P, Dell'Avvocata F, Giordan M, Braggion G, Chinaglia M, Roncon L. Cardiovasc Revasc Med; 2010 Nov 07; 11(1):29-33. PubMed ID: 20129358 [Abstract] [Full Text] [Related]
35. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Periprocedural safety and mid-term follow-up results of three different device occluder systems. Braun M, Gliech V, Boscheri A, Schoen S, Gahn G, Reichmann H, Haass M, Schraeder R, Strasser RH. Eur Heart J; 2004 Mar 07; 25(5):424-30. PubMed ID: 15033255 [Abstract] [Full Text] [Related]
36. Transcatheter closure of patent foramen ovale associated with paradoxical embolism using the amplatzer PFO occluder: initial and intermediate-term results of the U.S. multicenter clinical trial. Hong TE, Thaler D, Brorson J, Heitschmidt M, Hijazi ZM, Amplatzer PFO Investigators. Catheter Cardiovasc Interv; 2003 Dec 07; 60(4):524-8. PubMed ID: 14624434 [Abstract] [Full Text] [Related]
37. Transcatheter closure of patent foramen ovale in patients with migraine headache. Spies C, Schräder R. J Interv Cardiol; 2006 Dec 07; 19(6):552-7. PubMed ID: 17107372 [Abstract] [Full Text] [Related]
39. Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke. Thanopoulos BV, Dardas PD, Karanasios E, Mezilis N. Catheter Cardiovasc Interv; 2006 Nov 07; 68(5):741-6. PubMed ID: 17039525 [Abstract] [Full Text] [Related]